ADVANCED MALIGNANCY
Clinical trials for ADVANCED MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug ADCX-020 enters first human trials for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called ADCX-020 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody drug conjugate designed to deliver cancer-killing agents directly to tumor cells. The study will first find th…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New cancer drug SHR-7782 enters human testing
Disease control Recruiting nowThis early-stage trial is testing a new drug, SHR-7782, in 200 adults with advanced malignant cancer that has not responded to standard treatments. The main goals are to find the safest dose and check for side effects, while also watching for any tumor shrinkage. Participants mus…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study checks how liver issues affect cancer drug pelabresib
Knowledge-focused Recruiting nowThis early-phase study is testing the cancer drug pelabresib in 24 people with advanced cancers who also have liver problems. The goal is to see how the liver affects the drug levels in the body. Participants will take the drug daily for 14 days, then have a week off. This resear…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC